MedTrace Logo

Non-Invasive Monitoring of Traumatic Brain Injury Progression Using the Infrascanner (MOBI-1)

NCT04893837 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 399

Last updated 2025-09-02

No results posted yet for this study

Summary

MOBI-1 is a multicenter clinical trial that will evaluate the use of the Infrascanner for the monitoring of traumatic intracranial hematomas.

Conditions

  • Brain Injuries, Traumatic

Interventions

DEVICE

Standard care plus infrascans

Hourly infrascans to detect expanding intracranial hematomas

Sponsors & Collaborators

  • United States Department of Defense

    collaborator FED

  • InfraScan, Inc.

    collaborator INDUSTRY

  • University of Alabama at Birmingham

    lead OTHER

Principal Investigators

  • Jan O Jansen, MBBS, PhD · University of Alabama at Birmingham, Center for Injury Science

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-18
Primary Completion
2025-06-17
Completion
2025-08-25
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04893837 on ClinicalTrials.gov